Financiere de Tubize Valuation Multiples

Financiere de Tubize Overview

About Financiere de Tubize

Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.

Founded

N/A

HQ

Employees

0

Website

financiere-tubize.be

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: —

EBITDA: $111M

EV

$12B

Valuation Multiples

Multiples.vc

Start free trial

Financiere de Tubize Financials

Financiere de Tubize reported last fiscal year revenue of — and EBITDA of $111M.

In the same fiscal year, Financiere de Tubize generated ($3M) in gross profit, $111M in EBITDA, and $110M in net income.

Financiere de Tubize P&L

In the most recent fiscal year, Financiere de Tubize reported revenue of — and EBITDA of $111M.

Financiere de Tubize expects next 12-month revenue of XXX and NTM EBITDA of XXX

Financiere de Tubize Stock Performance

Financiere de Tubize has current market cap of $12B, and enterprise value of $12B.

Financiere de Tubize's stock price is $268.88.

Financiere de Tubize Valuation Multiples

Financiere de Tubize trades at 108.1x EV/EBITDA.

Financiere de Tubize Financial Valuation Multiples

As of April 18, 2026, Financiere de Tubize has market cap of $12B and EV of $12B.

Equity research analysts estimate Financiere de Tubize's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Financiere de Tubize has a P/E ratio of 109.0x.

Financiere de Tubize Margins & Growth Rates

Financiere de Tubize's revenue in the last fiscal year grew by —.

Financiere de Tubize Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Financiere de Tubize M&A Activity

Financiere de Tubize acquired XXX companies to date.

Last acquisition by Financiere de Tubize was on XXXXXXXX, XXXXX. Financiere de Tubize acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Financiere de Tubize Investment Activity

Financiere de Tubize invested in XXX companies to date.

Financiere de Tubize made its latest investment on XXXXXXXX, XXXXX. Financiere de Tubize invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).